Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2015 Aug 25;132(8):667-76.
doi: 10.1161/CIRCULATIONAHA.115.016163. Epub 2015 Jul 2.

Patient-Level Discordance in Population Percentiles of the Total Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Comparison With Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol: The Very Large Database of Lipids Study (VLDL-2B)

Mohamed B Elshazly  1 , Renato Quispe  2 , Erin D Michos  2 , Allan D Sniderman  2 , Peter P Toth  2 , Maciej Banach  2 , Krishnaji R Kulkarni  2 , Josef Coresh  2 , Roger S Blumenthal  2 , Steven R Jones  2 , Seth S Martin  2
Affiliations
Clinical Trial

Patient-Level Discordance in Population Percentiles of the Total Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Comparison With Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol: The Very Large Database of Lipids Study (VLDL-2B)

Mohamed B Elshazly et al. Circulation. .

Abstract

Background: The total cholesterol to high-density lipoprotein cholesterol (TC/HDL-C) ratio, estimated low-density lipoprotein cholesterol (LDL-C), and non-HDL-C are routinely available from the standard lipid profile. We aimed to assess the extent of patient-level discordance of TC/HDL-C with LDL-C and non-HDL-C, because discordance suggests the possibility of additional information.

Methods and results: We compared population percentiles of TC/HDL-C, Friedewald-estimated LDL-C, and non-HDL-C in 1 310 432 US adults from the Very Large Database of Lipids. Lipid testing was performed by ultracentrifugation (Vertical Auto Profile, Atherotech, AL). One in 3 patients had ≥25 percentile units discordance between TC/HDL-C and LDL-C, whereas 1 in 4 had ≥25 percentile units discordance between TC/HDL-C and non-HDL-C. The proportion of patients with TC/HDL-C > LDL-C by ≥25 percentile units increased from 3% at triglycerides <100 mg/dL to 51% at triglycerides 200 to 399 mg/dL. On a smaller scale, TC/HDL-C > non-HDL-C discordance by ≥25 percentile units increased from 6% to 21%. In those with <15th percentile levels of LDL-C (<70 mg/dL) or non-HDL-C (<93 mg/dL), a respective 58% and 46% were above the percentile-equivalent TC/HDL-C of 2.6. Age, sex, and directly measured components of the standard lipid profile explained >86% of the variance in percentile discordance between TC/HDL-C versus LDL-C and non-HDL-C.

Conclusions: In this contemporary, cross-sectional, big data analysis of US adults who underwent advanced lipid testing, the extent of patient-level discordance suggests that TC/HDL-C may offer potential additional information to LDL-C and non-HDL-C. Future studies are required to determine the clinical implications of this observation.

Clinical trial registration: URL: http://www.clinicaltrials.gov. Unique identifier: NCT01698489.

Keywords: cholesterol; lipids; lipoproteins; primary prevention.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Patient-level discordance between population percentiles of TC/HDL-C and LDL-C. Population percentiles of TC/HDL-C and LDL-C are presented on this plot for the whole population (A) and for four different triglyceride categories (B). Points to the left of the diagonal line represent individuals with TC/HDL-C percentile > LDL-C percentile and points to the right of the diagonal line represent individuals with TC/HDL-C percentile < LDL-C percentile. The density of data is expressed by different shades of color, which represent increasing densities of patients per pixel, from light blue to purple. The number next to each color on the color axis represents the maximum number of patients per pixel of this color. ρ is Spearman correlation coefficient. TC/HDL-C (Total Cholesterol to HDL-C ratio); LDL-C (Low-density Lipoprotein Cholesterol).
Figure 2
Figure 2
Patient-level discordance between population percentiles of TC/HDL-C and non-HDL-C. Population percentiles of TC/HDL-C and non-HDL-C are presented on this plot for the whole population (A) and for four different triglyceride categories (B). Points to the left of the diagonal line represent individuals with TC/HDL-C percentile > non-HDL-C percentile and points to the right of the diagonal line represent individuals with TC/HDL-C percentile < non-HDL-C percentile. The density of data is expressed by different shades of color, which represent increasing densities of patients per pixel, from light blue to purple. The number next to each color on the color axis represents the maximum number of patients per pixel of this color. ρ is Spearman correlation coefficient. TC/HDL-C (Total Cholesterol to HDL-C ratio); non-HDL-C (Non-High-density Lipoprotein Cholesterol).
Figure 3
Figure 3
3-D plot of the extent of discordance between TC/HDL-C, LDL-C and non-HDL-C percentiles across different percentile units thresholds. On the X-axis, we present discordance between TC/HDL-C and LDL-C percentiles, TC/HDL-C and non-HDL-C percentiles and LDL-C and non-HDL-C percentiles from left to right, respectively. On the Y-axis, we represent the magnitude (%) of patient-level discordance at thresholds of ≥5, ≥10, ≥25, and ≥50 percentile units. TC/HDL-C (Total Cholesterol to HDL-C ratio); LDL-C (Low-density Lipoprotein Cholesterol); non-HDL-C (Non-High-density Lipoprotein Cholesterol).
Figure 4
Figure 4
Proportions with LDL-C or non-HDL-C <15th population percentile but discordantly high TC/HDL-C. A) The proportion of patients with LDL-C < 70 mg/dL and TC/HDL-C ≥ 2.6 (15th percentile equivalent cut-points) across various triglyceride categories B) The proportion of patients with non-HDL-C < 93 mg/dL and TC/HDL-C ≥ 2.6 (15th percentile equivalent cut-points) across various triglyceride categories. TC/HDL-C (Total Cholesterol to HDL-C ratio); LDL-C (Low-density Lipoprotein Cholesterol); non-HDL-C (Non-High-density Lipoprotein Cholesterol).
Figure 4
Figure 4
Proportions with LDL-C or non-HDL-C <15th population percentile but discordantly high TC/HDL-C. A) The proportion of patients with LDL-C < 70 mg/dL and TC/HDL-C ≥ 2.6 (15th percentile equivalent cut-points) across various triglyceride categories B) The proportion of patients with non-HDL-C < 93 mg/dL and TC/HDL-C ≥ 2.6 (15th percentile equivalent cut-points) across various triglyceride categories. TC/HDL-C (Total Cholesterol to HDL-C ratio); LDL-C (Low-density Lipoprotein Cholesterol); non-HDL-C (Non-High-density Lipoprotein Cholesterol).
See this image and copyright information in PMC

References

    1. National Ambulatory Medical Care Survey. 2009 Summary Tables. [Accessed February 2, 2015]; http://www.cdc.gov/nchs/data/ahcd/namcs_summary/2009_namcs_web_tables.pdf. Published in December 2009.
    1. Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, Greenlund K, Daniels S, Nichol G, Tomaselli GF, Arnett DK, Fonarow GC, Ho PM, Lauer MS, Masoudi FA, Robertson RM, Roger V, Schwamm LH, Sorlie P, Yancy CW, Rosamond WD American Heart Association Strategic Planning Task Force and Statistics Committee. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation. 2010;12:586–613. - PubMed
    1. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC, Watson K, Wilson PWF, Eddleman KM, Jarrett NM, LaBresh K, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen W-K, Smith SC, Tomaselli GF American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S1–S45. - PubMed
    1. Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D, ESC Committee for Practice Guidelines (CPG) 2008–2010 and 2010–2012 Committees. Bax J, Vahanian A, Auricchio A, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Filippatos G, Funck-Brentano C, Hasdai D, Hobbs R, Hoes A, Kearney P, Knuuti J, Kolh P, McDonagh T, Moulin C, Poldermans D, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vardas P, Widimsky P, Windecker S, Reviewers D, Funck-Brentano C, Poldermans D, Berkenboom G, de Graaf J, Descamps O, Gotcheva N, Griffith K, Guida GF, Gulec S, Henkin Y, Huber K, Kesaniemi YA, Lekakis J, Manolis AJ, Marques-Vidal P, Masana L, McMurray J, Mendes M, Pagava Z, Pedersen T, Prescott E, Rato Q, Rosano G, Sans S, Stalenhoef A, Tokgozoglu L, Viigimaa M, Wittekoek ME, Zamorano JL. ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) Eur Heart J. 2011;32:1769–1818. - PubMed
    1. Anderson TJ, Grégoire J, Hegele RA, Couture P, Mancini GBJ, McPherson R, Francis GA, Poirier P, Lau DC, Grover S, Genest J, Jr, Carpentier AC, Dufour R, Gupta M, Ward R, Leiter LA, Lonn E, Ng DS, Pearson GJ, Yates GM, Stone JA, Ur E. 2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult. Can J Cardiol. 2013;29:151–167. - PubMed

Publication types

Associated data